<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Close association between <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> has been recently highlighted </plain></SENT>
<SENT sid="1" pm="."><plain>Indeed, <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD) has been strongly linked with an increased risk of development of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>Inflammatory cell-produced <z:mp ids='MP_0002501'>inflammatory mediators</z:mp>, such as proinflammatory cytokines and inducible enzymes, contribute to this association </plain></SENT>
<SENT sid="3" pm="."><plain>In an inflammatory microenvironment, infiltrating macrophages and mast cells mediate production of these <z:mp ids='MP_0002501'>inflammatory mediators</z:mp> to promote growth of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in target tissues </plain></SENT>
<SENT sid="4" pm="."><plain>In contrast to macrophages, contribution of mast cells to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> development in inflamed colon is not well understood </plain></SENT>
<SENT sid="5" pm="."><plain>This study aimed to determine the role of mast cells in <z:mp ids='MP_0001845'>inflammation</z:mp>-associated colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> was induced by administration of the colonic carcinogen, azoxymethane (AOM), and the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoter <z:chebi fb="0" ids="52071">dextran</z:chebi> <z:chebi fb="0" ids="32149">sodium sulfate</z:chebi> (DSS) in male mast cell-deficient WBBF(1)-kit (W/W-v) (W/W(v)) and mast cell-<z:mpath ids='MPATH_458'>normal</z:mpath> WBB6F(1)-+/+(WT) mice </plain></SENT>
<SENT sid="7" pm="."><plain>At week 12, the W/W(v) mice had markedly lower <z:mp ids='MP_0001845'>inflammation</z:mp> scores in the colon when compared with WT mice </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of colonic proinflammatory cytokines and inducible enzymes were also decreased in W/W(V) mice at weeks 12 and 20, when compared with WT counterparts </plain></SENT>
<SENT sid="9" pm="."><plain><z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">Colorectal tumors</z:e>, including <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, were identified by histopathological analysis performed 20Â weeks thereafter </plain></SENT>
<SENT sid="10" pm="."><plain>Importantly, there were less neoplastic and preneoplastic colonic lesions in the W/W(v) mice compared with the WT mice </plain></SENT>
<SENT sid="11" pm="."><plain>Thus, for the first time, our study shows that mice lacking mast cells are less susceptible to <z:mp ids='MP_0001845'>inflammation</z:mp>-associated colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>Our findings also suggest that mast cells and their selected cytokines could play an important role in <z:mp ids='MP_0001845'>inflammation</z:mp>-mediated <z:mp ids='MP_0002006'>tumorigenesis</z:mp> through regulation of proinflammatory cytokines and inducible inflammatory enzymes </plain></SENT>
</text></document>